A. D. Nardo, M. Schneeweiss-Gleixner, M. M. Bakail, E. D. Dixon, S. F. Lax, and M. Trauner, “Pathophysiological mechanisms of liver injury in COVID-19,” Liver International, vol. 41, no. 1. Wiley, pp. 20–32, 2021.

J. Mbianda et al., “Optimal anchoring of a foldamer inhibitor of AS histone chaperone through backbone plasticity,” Science Advances, vol. 7, no. 12. American Association for the Advancement of Science, 2021.

M. M. Bakail, S. RodriguezMarin, Z. Hegedüs, M. E. Perrin, F. Ochsenbein, and A. J. Wilson, “Recognition of AS by using hydrocarbonconstrained peptides,” ChemBioChem, vol. 20, no. 7. Wiley, pp. 891–895, 2019.

M. M. Bakail et al., “Design on a rational basis of high-affinity peptides inhibiting the histone chaperone AS,” Cell Chemical Biology, vol. 26, no. 11. Elsevier, p. 1573–1585.e10, 2019.

M. M. Bakail and F. Ochsenbein, “Targeting protein–protein interactions, a wide open field for drug design,” Comptes Rendus Chimie, vol. 19, no. 1–2. Elsevier, pp. 19–27, 2016.

N. Richet et al., “Structural insight into how the human helicase subunit MCM2 may act as a histone chaperone together with AS at the replication fork,” Nucleic Acids Research, vol. 43, no. 3. Oxford University Press, pp. 1905–1917, 2015.